Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2026Open Access

Urban Migrant Workers' Adherence to Tuberculosis Treatment in Johannesburg, South Africa: A Six-Month Retrospective Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

TMTshepo MokgatlaSMSiyabonga MkhizeCouncil for GeoscienceMMMxolisi Mafungwaghoza

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals low adherence to TB treatment in urban migrant workers, suggesting education interventions are needed.

Key Points

  • To investigate the adherence to TB treatment among urban migrant workers in Johannesburg.
  • Conducted a retrospective analysis of patient records from a public health clinic
  • Collected demographic information and treatment adherence metrics
  • Analyzed missed appointments and drug adherence scores
  • Only 65% of participants adhered to prescribed TB treatment
  • Males had higher adherence (70%) compared to females (60%)
  • Identified significant variability in treatment adherence among the population

Cite This Study

Mokgatla et al. (2010) studied this question.

synapsesocial.com/papers/69ada8c2bc08abd80d5bc0f9https://doi.org/10.5281/zenodo.18903950
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mobile Health Clinics and Tuberculosis Treatment Adherence in South African Townships: A Policy Analysis2012
  2. 2Community-Based Healthcare Model for Tuberculosis Prevention and Care in Johannesburg Informal Settlements: Six-Month Evaluation2013
  3. 3Factors associated with non-compliance to tuberculosis treatment among patients in Gauteng Province, South Africa2025
  4. 4Tuberculosis Control in South African Mining Communities: Adherence and Community Engagement Rates2011
  5. 5Baseline determinants of adherence for drug-sensitive TB treatment in a South African prospective cohort: a focus on HIV infection and anti-retroviral therapy, clinical care access, and TB stigma2024